FDA official logo
GSRS logo
PFDA official logo

ORITAVANCIN DIPHOSPHATE

  • UNII: VL1P93MKZN
  • Formula: C86H97Cl3N10O26.2H3O4P
  • Preferred Substance Name: ORITAVANCIN DIPHOSPHATE
  • InChIKey: PWTROOMOPLCZHB-BHYQHFGMSA-N

  • 192564-14-0
  • KIMYRSA
  • LY333328 DIPHOSPHATE
  • LY-333328 DIPHOSPHATE
  • NUVOCID
  • ORBACTIV
  • ORITAVANCIN DIPHOSPHATE [MI]
  • ORITAVANCIN DIPHOSPHATE [ORANGE BOOK]
  • ORITAVANCIN DIPHOSPHATE [USAN]
  • ORITAVANCIN DIPHOSPHATE [VANDF]
  • ORITAVANCIN DIPHOSPHATE [WHO-DD]
  • ORITAVANCIN PHOSPHATE [MART.]
  • VANCOMYCIN, 22-O-(3-AMINO-2,3,6-TRIDEOXY-3-C-METHYL-.ALPHA.-L-ARABINO-HEXOPYRANOSYL)-N3''-((4'-CHLORO(1,1'-BIPHENYL)-4-YL)METHYL)-, (4''R)-, PHOSPHATE (1:2)
  • VANCOMYCIN, 22-O-(3-AMINO-2,3,6-TRIDEOXY-3-C-METHYL-.ALPHA.-L-ARABINO-HEXOPYRANOSYL)-N3''-((4'-CHLORO(1,1'-BIPHENYL)-4-YL)METHYL)-, (4''R)-, PHOSPHATE (1:2) (SALT)

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.